Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques

NCT05088161 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.

NCT NCT05088161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05088161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
Lead sponsor
The Affiliated Hospital of Qingdao University
Phase
Observational
Overall status
Unknown status
Start date
May 13, 2021
Completion date
March 12, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients